STSA - Satsuma Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $3.56. This is a potential upside of $2.46 (223.64%) from yesterday's end of day stock price of $1.1.

Satsuma Pharmaceuticals's activity chart (see below) currently has 32 price targets and 27 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.9% with an average time for these price targets to be met of 107.8 days.

Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 18-Apr-2023. First documented stock forecast 08-Oct-2019.

Split History since 2000:

9/1/05 3 for 2

5/6/04 11 for 10

5/1/03 11 for 10

5/1/02 11 for 10

11/6/01 11 for 10

11/2/00 11 for 10

Best performing analysts who are covering STSA - Satsuma Pharmaceuticals:

Marc Goodman Evan Seigerman Vamil Divan Oren Livnat Stephen Kim

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$3

2 years 22 days ago
(18-Apr-2023)

1/6 (16.67%)

$2.29 (322.54%)

141

Buy

$14

2 years 5 months 24 days ago
(16-Nov-2022)

0/1 (0%)

$8.01 (133.72%)

Hold

$2

$0.9 (81.82%)

2 years 5 months 25 days ago
(15-Nov-2022)

3/7 (42.86%)

$1.37 (217.46%)

202

Hold

$1

$-0.1 (-9.09%)

$15

2 years 5 months 25 days ago
(15-Nov-2022)

2/4 (50%)

$0.37 (58.73%)

62

Sell

$6.5

$5.4 (490.91%)

$3.5

4 years 2 months 8 days ago
(02-Mar-2021)

5/5 (100%)

$0.25 (4.00%)

134

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STSA (Satsuma Pharmaceuticals) average time for price targets to be met?

On average it took 107.8 days on average for the stock forecasts to be realized with a an average price target met ratio 41.9

Which analyst has the current highest performing score on STSA (Satsuma Pharmaceuticals) with a proven track record?

MARC GOODMAN

Which analyst has the current lower performing score on STSA (Satsuma Pharmaceuticals) with a proven track record?

STEPHEN KIM

Which analyst has the most public recommendations on STSA (Satsuma Pharmaceuticals)?

Marc Goodman has 4 price targets and 1 ratings on STSA

Which analyst is the currently most bullish on STSA (Satsuma Pharmaceuticals)?

Evan Seigerman with highest potential upside - $5.4

Which analyst is the currently most reserved on STSA (Satsuma Pharmaceuticals)?

Marc Goodman with lowest potential downside - -$0.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?